Table 2 Risk factors for tumor recurrence.
 | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
Hazard ratio | p value | 95% CI | Hazard ratio | p value | 95% CI | |
Female | 0.76 | 0.37 | 0.42–1.38 |  |  |  |
Age ≥ 65 | 1.49 | 0.21 | 0.80–2.78 |  |  |  |
Simpson grade 1–3 | 0.16 | 9.7 × 10–10 | 0.09–0.29 | 0.21 | 1.9 × 10–6 | 0.11–0.39 |
MIB-1 LI ≥ 3 | 3.33 | 1.1 × 10–4 | 1.81–6.14 | 1.81 | 0.14 | 0.82–3.98 |
Meningothelial | 0.72 | 0.24 | 0.41–1.25 |  |  |  |
Transitional | 0.96 | 0.92 | 0.43–2.14 |  |  |  |
Fibrous | 0.47 | 0.11 | 0.19–1.19 | 1.00 | 0.99 | 0.32–3.14 |
WHO grade II | 6.44 | 3.9 × 10–9 | 3.46–12.0 | 4.99 | 1.2 × 10–4 | 2.20–11.3 |
Neural crest | 1.00 | 0.99 | 0.58–1.75 |  |  |  |
Paraxial mesoderm | 1.07 | 0.81 | 0.61–1.90 |  |  |  |
Dorsal mesoderm | 0.83 | 0.70 | 0.33–2.10 |  |  |  |
AKT1 mutation | 0.60 | 0.39 | 0.19–1.94 |  |  |  |
KLF4 mutation | 0.67 | 0.55 | 0.11–2.15 |  |  |  |
POLR2A mutation | 2.42 | 0.09 | 0.83–5.58 | 4.08 | 1.7 × 10–2 | 1.28–13.0 |
NF2 mutation or 22q loss | 1.48 | 0.18 | 0.84–2.72 | 1.81 | 0.15 | 0.81–4.04 |